FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models
Abstract Background We developed the FORCETM platform to overcome limitations of oligonucleotide delivery to muscle and enable their applicability to neuromuscular disorders. The platform consists of an antigen-binding fragment, highly specific for the human transferrin receptor 1 (TfR1), conjugated...
Saved in:
Main Authors: | Timothy Weeden, Tyler Picariello, Brendan Quinn, Sean Spring, Pei-Yi Shen, Qifeng Qiu, Benjamin F. Vieira, Lydia Schlaefke, Ryan J. Russo, Ya-An Chang, Jin Cui, Monica Yao, Aiyun Wen, Nelson Hsia, Tama Evron, Katy Ovington, Pei-Ni Tsai, Nicholas Yoder, Bo Lan, Reshmii Venkatesan, John Hall, Cody A. Desjardins, Mo Qatanani, Scott Hilderbrand, John Najim, Zhenzhi Tang, Matthew K. Tanner, Romesh Subramanian, Charles A. Thornton, Oxana Ibraghimov-Beskrovnaya, Stefano Zanotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-025-00733-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
by: Kyohei Yamaguchi, et al.
Published: (2019-01-01) -
Myotonic Steiner dystrophy in a family. Case Presentation
by: María Octavina Rodríguez Roque, et al.
Published: (2020-02-01) -
Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair
by: Ramon Go, et al.
Published: (2017-01-01) -
Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
by: Akihiro Kashiwai, et al.
Published: (2012-01-01) -
Surgical Orthodontic Treatment of a Patient Affected by Type 1 Myotonic Dystrophy (Steinert Syndrome)
by: Laura Cacucci, et al.
Published: (2017-01-01)